Welcome to our dedicated page for Quantinuum SEC filings (Ticker: QNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Quantinuum's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Quantinuum's regulatory disclosures and financial reporting.
Quantinuum Inc. director Manish H. Bhatia reported new equity activity in Class A Common Stock. On June 5, 2026, he made an open-market purchase of 20,000 shares at $60.00 per share, increasing his direct holdings to 25,833 shares. On June 4, 2026, he also received a grant of 5,833 restricted stock units (RSUs), each representing one share, which will vest in three equal annual installments beginning on June 5, 2027.
Quantinuum Inc. director and President & CEO Rajeeb Hazra reported a series of equity compensation awards and related tax withholding in Class A Common Stock. He received 1,042,561 restricted stock units, each representing a right to one share of Class A Common Stock, which will vest in four equal annual installments beginning on June 5, 2027. He was also granted 122,791 stock options with a $60.00 exercise price, scheduled to vest in four equal annual installments beginning on June 5, 2027. In addition, he acquired 78,333 shares of restricted Class A Common Stock in connection with a recapitalization transaction. To satisfy tax liabilities upon vesting of restricted stock, 336,389 shares were withheld by the issuer at $60.00 per share, which the filing specifies was not a market sale. Following these transactions, Hazra directly holds 784,505 shares of Class A Common Stock.
Quantinuum Inc. is conducting an initial public offering of 28,000,000 shares of Class A common stock at an initial public offering price of $60.00 per share, representing aggregate gross proceeds of $1,680,000,000. The shares are approved for listing on Nasdaq under the symbol QNT.
After this offering (assuming no exercise of the underwriters' option), 32,862,895 shares of Class A common stock will be outstanding. Quantinuum Inc. intends to use net proceeds to purchase newly issued Common Units of Quantinuum Holdings at a per-unit price tied to the offering price, and Quantinuum Inc. will hold a 12.6% economic interest in Quantinuum Holdings immediately following the offering. The underwriters have a 30-day option to purchase an additional 4,200,000 shares.
Quantinuum Inc. director Eric Branderiz filed an initial Form 3 as a reporting person for the company. The filing identifies his role as a director and, in the data provided, shows no reported purchases, sales, derivative exercises, or other transactions in Quantinuum securities.
Quantinuum Inc. Chief Financial Officer Nitesh Sharan filed an initial ownership report showing holdings of Class A Common Stock. The filing reports that he directly holds 289,798 shares, which are described in a footnote as shares of restricted stock.
Quantinuum Inc. filed an initial Form 3 showing Chief Commercial Officer Lawrence Joseph Stack’s equity stake in the company. He holds 178,337 shares of Class A Common Stock as restricted stock, reported as directly owned. This filing records his starting ownership position and does not reflect any recent buy or sell transaction.
Quantinuum Inc. filed an initial insider ownership report for director Manish H Bhatia on Form 3. The filing identifies him as a director but shows no reportable transactions, exercises, gifts, or restructurings and no current derivative positions in the summarized data.
Quantinuum Inc. executive Kevin Scott Dehoff, the company’s Chief Strategy Officer, has filed an initial Form 3 showing his equity position. He reports beneficial ownership of 111,460 shares of Class A Common Stock, which a footnote clarifies are held as restricted stock.
This filing does not record a new buy or sell transaction; it simply establishes Dehoff’s existing restricted stock holdings as he becomes a reporting insider.
Quantinuum Inc. filed an initial beneficial ownership report for director Vimal Kapur on Form 3. This filing identifies Kapur as a director of the company but, in the provided data, shows no equity transactions and no reported holdings or derivative positions at this time.
Quantinuum Inc. filed an initial insider ownership report for director Prineha Narang on Form 3. The data shows no reported transactions, with buy, sell, and derivative activity all at zero. The filing also lists zero holding entries, so no specific share positions are detailed.